Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis

Keyphrases

• Leukemia 100%
• Acute Myeloid Leukemia 100%
• Neurofibromatosis Type I 100%
• Neurofibromatosis Type 1 (NF-1) 100%
• Neurofibromatosis 100%
• Pediatric T-cell Acute Lymphoblastic Leukemia 100%
• In(III) 25%
• T-cell Acute Lymphoblastic Leukemia (T-ALL) 16%
• Pediatric 8%
• In Cancer 8%
• High Risk 8%
• Tumor Suppressor Gene 8%
• Autosomal Dominant 8%
• Acute Myeloid Leukemia Cells 8%
• Negative Regulator 8%
• Genetic Disease 8%
• Array Comparative Genomic Hybridization (aCGH) 8%
• Microdeletion 8%
• MRNA Level 8%
• Mutation Analysis 8%
• Oligoarray 8%
• GTPase-activating Protein 8%
• Ras GTPase 8%
• Juvenile Myelomonocytic Leukemia 8%
• Cryptic Deletion 8%
• Novel Type 8%

Medicine and Dentistry

• Pediatrics 100%
• Acute Lymphoblastic Leukemia 100%
• Leukemia 100%
• Acute Myeloid Leukemia 100%
• Neurofibromatosis Type I 100%
• Neurofibromatosis 100%
• Malignant Neoplasm 9%
• Allele 9%
• Genetic Disorder 9%
• Tumor Suppressor Gene 9%
• Autosomal Dominant Inheritance 9%
• Leukemia Cell 9%
• Array Comparative Genomic Hybridization 9%
• Juvenile Myelomonocytic Leukemia 9%
• Neurofibromin 1 9%
• Guanosine Triphosphatase Activating Protein 9%

Biochemistry, Genetics and Molecular Biology

• T Cell 100%
• Myeloid 100%
• Pediatrics 100%
• Allele 20%
• Genetic Disorder 20%
• Tumor Suppressor Gene 20%
• Autosomal Dominant Inheritance 20%
• RNA 20%
• Array Comparative Genomic Hybridization 20%
• GTPase-activating Protein 20%
• Neurofibromin 1 20%
• Expression Level 20%